Have a personal or library account? Click to login
Conservative Treatment for Congenital Nasolacrimal Duct Obstruction – Factors Affecting the Success Cover

Conservative Treatment for Congenital Nasolacrimal Duct Obstruction – Factors Affecting the Success

By: K. P. Valcheva and  S. V. Murgova  
Open Access
|Aug 2021

References

  1. 1. Guerry D, Kendig EL. Congenital impatency on the naso-lacrimal duct. Arch Ophthalmol, 1948, 39, 193-204.10.1001/archopht.1948.00900020198006
  2. 2. Khan N, Khan MN, Jan S, Mohammad S. Congenital Nasolacrimal Duct Obstruction: Presentation and Mangement. Pak J Ophthalmol, 2006, 22 (2), 74-78.
  3. 3. Zappia RJ, Milder B. Lacrimal drainage function: the fluorescein dye disappearance test. Am J Ophthalmol, 1972, 74, 160-162.10.1016/0002-9394(72)91142-7
  4. 4. MacEwen CJ, Young JDH. Epiphora During the First Year of Life. Eye (Lond), 1991, 5 (5), 596-600.10.1038/eye.1991.103
  5. 5. Ghuman T, Gonzales C, Mazon ML. Treatment of congenital nasolacrimal duct obstruction. Am J Orthopt, 1999, 49, 161-166.10.1080/0065955X.1999.11982207
  6. 6. Pediatric Eye Disease Investigator Group (PEDIG). Resolution of Congenital Nasolacrimal Duct Obstruction with Nonsurgical Management. Arch Ophthalmol, 2012, 130(6), 730-734.10.1001/archophthalmol.2012.454
  7. 7. Crigler LW. The treatment of congenital dacryocystitis. JAMA, 1923, 81, 23-24.10.1001/jama.1923.02650010027009
  8. 8. Nelson LB, Calhoun JH, Menduke H. Medical Management of Congenital Nasolacrimal Duct Obstruction. Ophthalmology, 1985, 92, 1187-1190.10.1016/S0161-6420(85)33878-2
  9. 9. Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol, 2010, 88(5), 506-513.10.1111/j.1755-3768.2009.01592.x19681790
  10. 10. MacEwen CJ, Young JDH. The fluorescein disappearance test: an evaluation of its use in infants. J Pediatr Ophthalmol Strab, 1991, 28, 302-305.10.3928/0191-3913-19911101-041757852
  11. 11. Dareshani S, Saleem T, Quraishy MM. Crigler Massage In Congenital Nasolacrimal Duct Obstruction. Medical Chanel, 2013, 19 (4), 21-23.
  12. 12. Kakizaki H, Takahashi Y, Kinoshita S, et al. The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clinical Ophthalmology, 2008, 2(2), 291-294.10.2147/OPTH.S2582269398119668718
  13. 13. Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital buct obstruction. Ophthalmology, 1987, 94, 698-705.10.1016/S0161-6420(87)33392-5
  14. 14. Young JDH, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: A multicentre trial of management. Eye, 1996, 10, 485-491.10.1038/eye.1996.1078944104
DOI: https://doi.org/10.2478/amb-2021-0019 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 25 - 28
Submitted on: Aug 11, 2020
Accepted on: Oct 12, 2020
Published on: Aug 11, 2021
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 K. P. Valcheva, S. V. Murgova, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.